Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > FDA Tracker Confirms October 8 date for ONCY
View:
Post by JohnnyYeg on Feb 15, 2024 5:27pm

FDA Tracker Confirms October 8 date for ONCY

Go to this link, go to October 8, 2024 and there it is - ONCY meeting date

FDA Tracker
Comment by canadafan on Feb 15, 2024 5:55pm
I have no idea what that October FDA meeting. Means? Good news?
Comment by Noteable on Feb 15, 2024 6:33pm
The FDA tracker cited is a private site created by Joseph Lee ... and by the ONCY PDUFA  example, his "creation" is serously flawed for reasons already provided, simply because no company is able to apply for a supplement BLA (sBLA) without having a biological license already approved. And he would have no insider information on upcoming Accelerated Approvals whatsoever. https ...more  
Comment by Noteable on Feb 15, 2024 6:40pm
From Adam N. - a Stocktwits poster:  https://stocktwits.com/Jutelure/message/561860111 Jutelure 20m   @JohnnyC63 that's for BMY, not ONCY. "Bristol Myers Squibb (NYSE: BMY) recently announced two regulatory acceptances for applications for neoadjuvant Opdivo (nivolumab) with chemotherapy followed by surgery and ...more  
Comment by JohnnyYeg on Feb 15, 2024 8:33pm
Thanks Noteable. Contacted FDA Calendar and they have corrected it. From now on, I will ONLY accept official "news" directly from ONCY
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities